We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Millipore First to Offer Full-length Biologically Relevant mTOR

Read time: Less than a minute

Millipore Corporation has announced the availability of its full-length mTOR kinase as part of the KinaseProfiler™ Service. This kinase is the first biologically relevant mTOR to be commercially available.

The KinaseProfiler Service offers 264 kinases for selectivity profiling, using a catalytic radiometric assay format. The addition of the full-length mTOR to the KinaseProfiler panel provides high-quality, confidential screening of compounds against this critically important kinase.

The mTOR kinase has recently been linked to many important human diseases, including cancer, diabetes, obesity, cardiovascular disease ad neurological disorders. The kinase enables the regulation of cell cycle progression, cell growth, protein synthesis, ribosome biogenesis and autophagy, important target factors in the study of mTOR related diseases.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.